Robotic Endoluminal Surgery Market Trends And Growth Drivers Point To Strong Future Potential
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expAnded supply chain intelligence, emerging startup coverage, And detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable And strategically valuable research.
Robotic Endoluminal Surgery Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The robotic endoluminal surgery market has seen significant expansion in recent years. This market is expected to increase from $1.45 billion in 2025 to $1.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.4%. The historical development of this market is attributable to the rising demAnd for minimally invasive procedures, increased adoption of endoscopic technologies, a growing preference for shorter hospital stays, the expAnding utilization of robotic-assisted surgeries, And the necessity for greater precision in accessing challenging anatomies.
The robotic endoluminal surgery market is projected for significant expansion over the coming years. This market is predicted to reach $3.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. Several factors are expected to fuel this growth during the projection period, including increased funding for surgical robotics research, the increasing incorporation of AI And machine learning into surgical platforms, the expAnding availability of flexible robotic systems, broader clinical applications for gastrointestinal And vascular surgeries, And a greater patient demAnd for quicker recovery times And less invasive treatments. Key trends anticipated during this period encompass technological progress in flexible robotic endoscopes, novel developments in capsule And micro-robotic devices, enhancements in AI-powered navigation systems, ongoing research And development in autonomous robotic surgery, And improvements in real-time imaging And robotic visualization technologies.
Download A Free Sample Report For Comprehensive Market Insights:
Robotic Endoluminal Surgery Market Industry Drivers: What Is Driving Revenue Growth?
The increasing acceptance of minimally invasive surgeries is anticipated to drive the expansion of the robotic endoluminal surgery market. Minimally invasive surgeries are surgical procedures carried out via small incisions or a single entry point, which lessens patient trauma, shortens recovery time, And reduces the risk of complications. The preference for minimally invasive surgeries is growing as both hospitals And patients increasingly prioritize benefits like shorter recovery periods, less postoperative discomfort, reduced complication risks, And minimal scarring compared to conventional open surgeries. Robotic endoluminal surgery facilitates these minimally invasive approaches by enabling accurate navigation And manipulation inside internal lumens, such as the gastrointestinal or respiratory tracts. This results in improved patient outcomes by minimizing tissue trauma, accelerating recovery, And enhancing the precision of procedures. For instance, Intuitive Surgical Inc., a US-based medical technology company, stated in January 2025 that worldwide da Vinci procedures, a form of minimally invasive robotic-assisted surgery, increased by approximately 18% in the fourth quarter of 2024 compared to the fourth quarter of 2023. Additionally, full year 2024 procedures saw growth of approximately 17% over 2023, And the company projects an increase of approximately 13% to 16% in worldwide da Vinci procedures in 2025 relative to 2024. Therefore, the rising adoption of minimally invasive And single-port surgeries is a primary factor propelling the growth of the robotic endoluminal surgery market.
#Robotic Endoluminal Surgery Market Segment LAndscape And Growth Potential
The robotic endoluminal surgery market covered in this report is segmented –
1) By Product Type: Surgical Systems, Accessories And Instruments, Services
2) By Application: Gastrointestinal Surgery, Urological Surgery, Pulmonary Surgery, Gynecological Surgery, Others
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
Subsegments:
1) By Surgical Systems: Flexible Endoscopic Robots, Bronchoscopy Robots, Gastrointestinal Navigation Robots, Colorectal Endoluminal Robots, Esophageal Endoscopic Robots
2) By Accessories And Instruments: Robotic Endoscopic Tools, Robotic Catheters, Robotic Endoscopic Cameras, Robotic Biopsy Devices, Robotic Graspers And Scissors
3) By Services: Installation And Integration Services, Maintenance And Repair Services, Training And Education Services, Software Upgrade Services, Technical Support Services
#Robotic Endoluminal Surgery Market Growth Trends: What Is Influencing The Future Outlook?
Major companies operating in the robotic endoluminal surgery market are prioritizing the creation of sophisticated technologies, including integrated artificial intelligence And real-time imaging systems, to elevate procedural exactness, heighten patient safety, And refine diagnostic effectiveness. These integrated AI And advanced imaging systems denote software improvements that combine machine learning with real-time procedural information. Their purpose is to assist medical professionals in navigating intricate anatomical structures And identifying target tissues with enhanced accuracy. As an example, during October 2025, Intuitive Surgical Inc., a medical technology firm based in the US, secured clearance from the U.S. Food & Drug Administration (FDA) for upgrades to the Ion endoluminal system’s software. These approved innovations feature improved 3D visualization of the lung’s airway tree And incorporate AI-powered imaging capabilities, assisting in detecting suspicious lung lesions throughout biopsy procedures. The aim of this integration is to offer more intuitive navigation And relevant data, thereby supporting physicians’ decisions for obtaining more exact tissue samples. Ultimately, it seeks to enhance the system’s effectiveness in the early detection of lung cancer, which could potentially result in improved patient outcomes.
Robotic Endoluminal Surgery Market Competitive LAndscape: Who Are The Leading Companies?
Major companies operating in the robotic endoluminal surgery market are Medtronic plc, Fujifilm Holdings Corporation, Intuitive Surgical Inc., Olympus Corporation, CMR Surgical Ltd., Noah Medical Inc., Distalmotion SA, Ronovo Surgical Inc., Stereotaxis Inc., Neocis Inc., MicroPort MedBot Co. Ltd., Virtual Incision Corporation, Asensus Surgical Inc., EndoQuest Robotics Inc., SS Innovations International Inc., Edge Medical Robotics, Moon Surgical, Robocath SAS, SurgEase Innovations, EndoTools Therapeutics SA, Microbot Medical Inc.
Access The Complete Robotic Endoluminal Surgery Market Report:
#Robotic Endoluminal Surgery Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the robotic endoluminal surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic endoluminal surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model